Friday, 18 April 2008 6:49 A GMT-06
Biotech investing is fraught with pitfalls. One of the best discussions of what a sophisticated investor should look for is Adam Feuerstein's article, "How to Review Biotech Clinical Data." He exposes some of the data trickery used by I